Literature DB >> 6093216

[Neuropathy with contractures evoking the stiff-man syndrome. Latent solitary plasmacytoma].

G Aimard, D Boisson, N Kopp, M Devic.   

Abstract

A further case of apparently primary sensorimotor neuropathy is reported. The patient, a 31-year-old man, developed the syndrome after a 4-year history of a solitary vertebral plasmocytoma revealed by post mortem examination. Circulating monoclonal immunoglobulin and specific anomalies on nerve biopsy were absent. The condition became progressively worse, with initial and predominant autonomic nervous system anomalies. After 3 years, contractures of the limbs and paravertebral muscles, with painful paroxysmal attacks suggestive of the stiff-man syndrome appeared. Pathology confirmed the severity of the root lesions with diffusion to the cranial nerves. Reflex tests could not be conducted but the semiologic characteristics and the efficacity of baclofen were distinctive of continuous muscle fiber activities reported in some peripheral neuropathies. This case was comparable to some reported ones of interneuron rigidity.

Entities:  

Mesh:

Year:  1984        PMID: 6093216

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  2 in total

1.  Autoimmune myastenia gravis with thymoma following the spontaneous remission of stiff-man syndrome.

Authors:  G Piccolo; G Martino; A Moglia; A Arrigo; V Cosi
Journal:  Ital J Neurol Sci       Date:  1990-04

2.  Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.

Authors:  Pascal Schlosser; Yong Li; Peggy Sekula; Johannes Raffler; Franziska Grundner-Culemann; Maik Pietzner; Yurong Cheng; Matthias Wuttke; Inga Steinbrenner; Ulla T Schultheiss; Fruzsina Kotsis; Tim Kacprowski; Lukas Forer; Birgit Hausknecht; Arif B Ekici; Matthias Nauck; Uwe Völker; Gerd Walz; Peter J Oefner; Florian Kronenberg; Robert P Mohney; Michael Köttgen; Karsten Suhre; Kai-Uwe Eckardt; Gabi Kastenmüller; Anna Köttgen
Journal:  Nat Genet       Date:  2020-01-20       Impact factor: 38.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.